Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 221.50
+4.50 (2.07%)
Apr 16, 2026, 4:52 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 478.01 million as of April 16, 2026. Its market cap has decreased by -2.06% in one year.
Market Cap
478.01M
Enterprise Value
542.83M
Revenue
228.94M
Ranking
n/a
PE Ratio
49.00
Stock Price
221.50
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 478.01M, an increase of 4,203.63%. That is a compound annual growth rate of 15.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 478.01M | 1.66% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.38B |
| GSK plc | 87.49B |
| Haleon | 31.84B |
| Smith & Nephew | 10.79B |
| Oxford Biomedica | 755.63M |
| Allergy Therapeutics | 677.58M |
| Spire Healthcare Group | 622.53M |
| Craneware | 500.93M |